Plasma-derived phosphoglycerate mutase 5 as a biomarker for Parkinson’s disease

BACKGROUND: We aimed to examine whether plasma-derived phosphoglycerate mutase 5 (PGAM5) can be a biomarker for Parkinson’s disease (PD) diagnosis as well as its association with the severity of motor/non-motor manifestations of PD. METHODS: We enrolled 124 patients with PD (PD group) and 50 healthy...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Liang, He, Haijun, Xiong, Xi, Xia, Kai, Qian, Shuangjie, Ye, Qianqian, Feng, Feifei, Zhou, Shuoting, Hong, Xianchai, Liu, Yiming, Xie, Chenglong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Aging Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661922/
https://www.ncbi.nlm.nih.gov/pubmed/36389083
http://dx.doi.org/10.3389/fnagi.2022.1022274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661922/
https://www.ncbi.nlm.nih.gov/pubmed/36389083
http://dx.doi.org/10.3389/fnagi.2022.1022274

Ejemplares similares